Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 277
7
Diseases
3
Unique genes
0.438
Avg. similarity score
Masa syndrome
Most-connected disease (6 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Masa syndrome
Partial corpus callosum agenesis, x-linked
X-linked complicated corpus callosum dysgenesis
X-linked complicated spastic paraplegia
X-linked hydrocephalus with stenosis of the aqueduct of sylvius
L1 syndrome
X-linked hydrocephalus syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Masa syndrome | 6 | 6 | 1 |
| Partial corpus callosum agenesis, x-linked | 6 | 6 | 1 |
| X-linked complicated corpus callosum dysgenesis | 6 | 6 | 1 |
| X-linked complicated spastic paraplegia | 6 | 6 | 1 |
| X-linked hydrocephalus with stenosis of the aqueduct of sylvius | 6 | 6 | 1 |
| L1 syndrome | 5 | 5 | 1 |
| X-linked hydrocephalus syndrome | 5 | 5 | 3 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| L1CAM | 7 / 7 | L1 syndrome, Masa syndrome, Partial corpus callosum agenesis, x-linked, X-linked complicated corpus callosum dysgenesis and 3 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Recycling pathway of L1 | Reactome | 2 / 40 | 200× | 3.24e-5 | 8.90e-4 ✓ sig. |
| L1CAM interactions | Reactome | 1 / 4 | 1,001× | 9.99e-4 | 1.35e-2 ✓ sig. |
| Interaction between L1 and Ankyrins | Reactome | 1 / 13 | 308× | 3.24e-3 | 3.26e-2 ✓ sig. |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | Reactome | 1 / 18 | 222× | 4.49e-3 | 4.08e-2 ✓ sig. |
| Cilium Assembly | Reactome | 1 / 19 | 211× | 4.74e-3 | 4.23e-2 ✓ sig. |
| Signal transduction by L1 | Reactome | 1 / 21 | 191× | 5.24e-3 | 4.50e-2 ✓ sig. |
| Basigin interactions | Reactome | 1 / 25 | 160× | 6.23e-3 | 5.06e-2 |
| Carboxyterminal post-translational modifications of tubulin | Reactome | 1 / 27 | 148× | 6.73e-3 | 5.32e-2 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | Reactome | 1 / 31 | 129× | 7.72e-3 | 5.83e-2 |
| RHO GTPases activate IQGAPs | Reactome | 1 / 32 | 125× | 7.97e-3 | 5.96e-2 |
| Aggrephagy | Reactome | 1 / 40 | 100× | 9.96e-3 | 6.82e-2 |
| COPI-independent Golgi-to-ER retrograde traffic | Reactome | 1 / 51 | 78.5× | 1.27e-2 | 7.88e-2 |
| Intraflagellar transport | Reactome | 1 / 54 | 74.1× | 1.34e-2 | 8.14e-2 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) | Reactome | 1 / 55 | 72.8× | 1.37e-2 | 8.23e-2 |
| Hedgehog 'off' state | Reactome | 1 / 56 | 71.5× | 1.39e-2 | 8.32e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| axon guidance | GO:0007411 | 2 / 192 | 64.9× | 3.13e-4 | 6.93e-3 ✓ sig. |
| cell killing | GO:0001906 | 1 / 2 | 3,115× | 3.21e-4 | 7.03e-3 ✓ sig. |
| cell migration | GO:0016477 | 2 / 303 | 41.1× | 7.78e-4 | 1.28e-2 ✓ sig. |
| dorsal root ganglion development | GO:1990791 | 1 / 5 | 1,246× | 8.03e-4 | 1.30e-2 ✓ sig. |
| maintenance of cell polarity | GO:0030011 | 1 / 7 | 890× | 1.12e-3 | 1.62e-2 ✓ sig. |
| netrin-activated signaling pathway | GO:0038007 | 1 / 9 | 692× | 1.44e-3 | 1.87e-2 ✓ sig. |
| positive regulation of axon extension | GO:0045773 | 1 / 31 | 201× | 4.97e-3 | 3.66e-2 ✓ sig. |
| response to food | GO:0032094 | 1 / 33 | 189× | 5.29e-3 | 3.78e-2 ✓ sig. |
| determination of adult lifespan | GO:0008340 | 1 / 38 | 164× | 6.09e-3 | 4.05e-2 ✓ sig. |
| axon development | GO:0061564 | 1 / 40 | 156× | 6.41e-3 | 4.15e-2 ✓ sig. |
| microtubule-based process | GO:0007017 | 1 / 46 | 135× | 7.37e-3 | 4.44e-2 ✓ sig. |
| synapse organization | GO:0050808 | 1 / 72 | 86.5× | 1.15e-2 | 5.51e-2 |
| post-embryonic development | GO:0009791 | 1 / 82 | 76.0× | 1.31e-2 | 5.86e-2 |
| neuron apoptotic process | GO:0051402 | 1 / 98 | 63.6× | 1.57e-2 | 6.37e-2 |
| cell-matrix adhesion | GO:0007160 | 1 / 105 | 59.3× | 1.68e-2 | 6.58e-2 |